Ascites
108
11
12
50
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
12 terminated out of 108 trials
80.6%
-5.9% vs benchmark
23%
25 trials in Phase 3/4
20%
10 of 50 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 50 completed trials
Clinical Trials (108)
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®
Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
High Dose Albumin in Refractory Ascites
VICIS - Vienna Cirrhosis Study
Free Fluid Detection With Telementored eFAST
Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites
Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic Experiment
Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents
Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites
Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients
Comparative Study of Secondary Prophylaxis for SBP
Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer
High Definition Profiling of Ovarian Cancer Ascites
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites